AngioDynamics ANGO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$33.99M+81.6% | -$184.35M-252% | -$52.44M-57.6% | -$33.29M-5.5% | ||
| $25.8M-6.9% | $27.71M-10.2% | $30.87M+5.2% | $29.35M+13.2% | ||
| $9.77M-7.2% | $10.53M-5.6% | $11.16M+4.4% | $10.69M+24.0% | ||
| —— | —— | —— | —— | ||
| $4.46M+77.3% | $2.52M-33.9% | $3.81M-11.3% | $4.3M-17.2% | ||
| -$10.18M— | —— | -$9.75M+49.5% | -$19.31M-40.8% | ||
| —— | $0— | $0— | —— | ||
| -$255K+99.6% | -$64.94M-355% | $25.42M+231% | $7.68M+145% | ||
| —— | $33.83M+114% | $15.8M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AngioDynamics generate?
- AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
- What is AngioDynamics's free cash flow?
- After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
- Where does AngioDynamics's cash flow data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
